Current Drug Delivery
Title: Editorial [Hot Topic: Functional Complementation, Molecular Targeted Strategies, and Chemo/Immuno-Sensitization in Cancer Treatment: Hurdles and Solutions (Guest Editor: A.R. Jazirehi)]
Volume: 9 Issue: 1
Author(s): Ali R. Jazirehi
Affiliation:
Keywords: Targeted therapy, signal transduction, sensitization, apoptosis, resistance, molecular signatures, molecular targeting, adoptive cell therapy, chemotherapy, death signaling pathways, apoptosis resistance, functional complementation, Bcl-2 members, death receptors, transcription factors
Export Options
About this article
Cite this article as:
R. Jazirehi Ali, Editorial [Hot Topic: Functional Complementation, Molecular Targeted Strategies, and Chemo/Immuno-Sensitization in Cancer Treatment: Hurdles and Solutions (Guest Editor: A.R. Jazirehi)], Current Drug Delivery 2012; 9 (1) . https://dx.doi.org/10.2174/156720112798376069
DOI https://dx.doi.org/10.2174/156720112798376069 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanotechnology: A Modern Contraption in Cosmetics and Dermatology
Applied Clinical Research, Clinical Trials and Regulatory Affairs Ligand-Based Pharmacophore Modeling, Atom-Based 3D-QSAR and Molecular Docking Studies on Substituted Thiazoles and Thiophenes as Polo-Like Kinase 1 (Plk1) Inhibitors
Combinatorial Chemistry & High Throughput Screening Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy
Current Cancer Drug Targets Acknowledgements to Reviewers
Clinical Cancer Drugs Pterostilbene as a Potential Novel Telomerase Inhibitor: Molecular Docking Studies and Its in vitro Evaluation
Current Pharmaceutical Biotechnology Inhaled Biologics: From Preclinical to Product Approval
Current Pharmaceutical Design Epidemiology and Management of Acute Kidney Injury in Hepatocellular Carcinoma Patients Undergoing Transcatheter Arterial Chemoembolization
Current Protein & Peptide Science Computational Methods and Algorithms for Mass-Spectrometry Based Differential Proteomics
Current Proteomics A Concise Review on Multidimensional Silver Nanoparticle Health Aids and Threats
Current Drug Therapy Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Hsp90 Inhibitors as Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry Challenges in Managing Amniotic Fluid Embolism: An Up-to-Date Perspective on Diagnostic Testing with Focus on Novel Biomarkers and Avenues for Future Research
Current Pharmaceutical Biotechnology Genomic Sequencing of Key Genes in Mouse Pancreatic Cancer Cells
Current Molecular Medicine A Review of Nutrition Education: Before, Between and Beyond Pregnancy
Current Women`s Health Reviews Epigenomic-Basis of Preemptive Medicine for Neurodevelopmental Disorders
Current Genomics The Importance of NAD in Multiple Sclerosis
Current Pharmaceutical Design Targeting Angiogenesis in Ovarian Carcinoma
Current Cancer Therapy Reviews Anti-Angiogenic Agents and Cancer: Current Insights and Future Perspectives
Recent Patents on Anti-Cancer Drug Discovery Blood Immunoglobulins, Complement and TNF Receptor Following Minimally Invasive Surgery in Patients Undergoing Pulmonary Lobectomy
Current Metabolomics The Role of Stromal Components in Pancreatic Cancer Progression
Anti-Cancer Agents in Medicinal Chemistry